Heart rate data as produced by the subjects under investigation both in resting conditions and taken as total means per trial initially showed a trend towards ergotropic, clearly tachycardiac behavior; with the onset of thymoleptic drug therapy, there followed a further increase in heart rate, frequencies remaining more or less stationary on this level during the 26-day period observed by us. We found differences between morning and evening data of session A with 50 % of subjects, 25 % showing higher frequencies in their morning data, the reverse applying to a further 25 %. The remaining 50 % did not show any differences worth mentioning. At the end of the investigation period, the relation changed in favor of an increase in heart rate in the evening with 50 % of subjects, whereas only 12.5 % showed increased heart rate jn the morning; 37.5 % did not show significant differences. We could not demonstrate these results to be related to diurnal variation, degree of depression or course of the disease.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.